Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (226) 226
life sciences & biomedicine (223) 223
humans (179) 179
respiratory system (162) 162
general & internal medicine (96) 96
pulmonary fibrosis (83) 83
idiopathic pulmonary fibrosis (77) 77
critical care medicine (68) 68
lung diseases (68) 68
abridged index medicus (66) 66
female (62) 62
male (61) 61
idiopathic pulmonary fibrosis - drug therapy (50) 50
diagnosis (42) 42
middle aged (41) 41
aged (39) 39
disease progression (36) 36
patients (36) 36
fibrosis (34) 34
idiopathic pulmonary fibrosis - diagnosis (34) 34
treatment outcome (34) 34
adult (29) 29
clinical trials (29) 29
interstitial lung disease (29) 29
biological and medical sciences (28) 28
medical sciences (28) 28
medicine, general & internal (28) 28
respiratory tract diseases (27) 27
pirfenidone (25) 25
idiopathic pulmonary fibrosis - physiopathology (23) 23
nintedanib (23) 23
risk factors (23) 23
pneumonia (22) 22
tuberculosis (22) 22
indoles - therapeutic use (21) 21
infectious diseases (21) 21
research (21) 21
care and treatment (20) 20
health aspects (20) 20
biopsy (19) 19
drug therapy (19) 19
medicine (19) 19
mortality (19) 19
idiopathic pulmonary fibrosis - therapy (18) 18
pneumology (18) 18
tuberculosis - diagnosis (18) 18
clinical medicine (16) 16
randomized controlled trials as topic (16) 16
diseases of the respiratory system (15) 15
pyridones - therapeutic use (15) 15
development and progression (14) 14
lung diseases, interstitial (14) 14
lung diseases, interstitial - diagnosis (14) 14
tomography, x-ray computed (14) 14
analysis (13) 13
lungs (13) 13
pharmacology & pharmacy (13) 13
pulmonary/respiratory (13) 13
quality of life (13) 13
evidence-based medicine (12) 12
indoles - administration & dosage (12) 12
internal medicine (12) 12
studies (12) 12
treatment (12) 12
tuberculin test (12) 12
aged, 80 and over (11) 11
immunology (11) 11
indoles - adverse effects (11) 11
interstitial lung diseases (11) 11
lung - diagnostic imaging (11) 11
medical research (11) 11
prognosis (11) 11
sarcoidosis (11) 11
sensitivity and specificity (11) 11
usage (11) 11
vital capacity (11) 11
animals (10) 10
cardiac & cardiovascular systems (10) 10
cardiovascular system & cardiology (10) 10
covid-19 (10) 10
diagnosis, differential (10) 10
disease (10) 10
drug dosages (10) 10
idiopathic pulmonary fibrosis - mortality (10) 10
medical diagnosis (10) 10
original (10) 10
review (10) 10
severity of illness index (10) 10
anti-inflammatory agents, non-steroidal - therapeutic use (9) 9
asthma (9) 9
clinical trials as topic (9) 9
comorbidity (9) 9
idiopathic pulmonary fibrosis - epidemiology (9) 9
life sciences (9) 9
lung - pathology (9) 9
medical prognosis (9) 9
practice guidelines as topic (9) 9
respiratory function (9) 9
respiratory system : syndromes and miscellaneous diseases (9) 9
vital capacity - drug effects (9) 9
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text An Update on the Diagnosis of Tuberculosis Infection
by Richeldi, Luca
American journal of respiratory and critical care medicine, ISSN 1073-449X, 10/2006, Volume 174, Issue 7, pp. 736 - 742
Blood test | Tuberculosis | Diagnosis | Interferon-γ | Respiratory System | Life Sciences & Biomedicine | Critical Care Medicine | General & Internal Medicine | Science & Technology | Infectious diseases | Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy | Viral diseases | Viral diseases of the lymphoid tissue and the blood. Aids | Biological and medical sciences | Intensive care medicine | Emergency and intensive care: infection, septic shock | Medical sciences | Human viral diseases | Enzyme-Linked Immunosorbent Assay | Humans | False Negative Reactions | Antigens, Bacterial | False Positive Reactions | Tuberculin Test | Tuberculosis, Pulmonary - prevention & control | Disease Progression | Mycobacterium tuberculosis - isolation & purification | Bacterial Proteins | Immunologic Tests - methods | Tuberculosis, Pulmonary - diagnosis | Sensitivity and Specificity | Interferon-gamma - blood | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Idiopathic pulmonary fibrosis
by Richeldi, Luca, Prof and Collard, Harold R, MD and Jones, Mark G, PhD
The Lancet (British edition), ISSN 0140-6736, 2017, Volume 389, Issue 10082, pp. 1941 - 1952
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Idiopathic Pulmonary Fibrosis - therapy | Idiopathic Pulmonary Fibrosis - diagnosis | Idiopathic Pulmonary Fibrosis - etiology | Humans | Respiratory tract diseases | Pulmonary fibrosis | Brain | Respiratory function | Pathogenesis | Defensive behavior | Acetylcysteine | Positive feedback | Epidemiology | Silica | Blood | Risk factors | Incidence | Proteins | Degradation | Alterations | Surgery | Cell adhesion | Stiffness | Diagnosis | Genetic factors | Catenin | Growth factors | Movement disorders | Basal cells | Exposure | Laparoscopy | Gene expression | Epithelium | Survival | Pathology | Gas exchange | Aberration | Azathioprine | Smoking | Farming | Pneumonia | Viruses | Activation | Respiratory tract | Historical account | Agriculture | Safety | Alveoli | Injuries | Deposition | Immune system | Biodegradation | Stomach | Lung diseases | Health risks | Pharmacology | Cigarette smoking | Inhalation | Concentration (composition) | Control theory | Pharmacokinetics | Brain injury | Apoptosis | Polymorphism | Biomedical research | Disease | Kinases | Disease control | Patients | Cell adhesion & migration | Fibrosis | Stem cells | Fibroblasts | Extracellular matrix | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Targeted treatment of idiopathic pulmonary fibrosis: One step at a time
by Richeldi, Luca
The European respiratory journal, ISSN 0903-1936, 05/2016, Volume 47, Issue 5, pp. 1321 - 1323
Life Sciences & Biomedicine | Respiratory System | Science & Technology
Journal Article
Details down arrow
4. Full Text Idiopathic pulmonary fibrosis: Moving forward
by Richeldi, Luca
BMC medicine, ISSN 1741-7015, 09/2015, Volume 13, Issue 1, pp. 231 - 231
Patient-reported outcomes | Interstitial lung disease | Staging | Epidemiology | High-resolution computed tomography | Idiopathic pulmonary fibrosis | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Idiopathic Pulmonary Fibrosis - genetics | Prognosis | Lung Diseases, Interstitial - genetics | Humans | Incidence | Research | Oncology, Experimental | Cancer | Medicine | Pulmonary fibrosis | Lung diseases | Mortality | Clinical trials | Behavior | Cancer therapies | Patients | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text COVID-19 and Interstitial Lung Disease: Keep Them Separate
by Podolanczuk, Anna J and Richeldi, Luca
American journal of respiratory and critical care medicine, ISSN 1073-449X, 12/2020, Volume 202, Issue 12, pp. 1614 - 1616
COVID-19 | Lung Diseases, Interstitial - diagnostic imaging | SARS-CoV-2 | Lung - diagnostic imaging | Humans | Case-Control Studies | Severe acute respiratory syndrome coronavirus 2 | Antibodies | Pandemics | Risk factors | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Treatments for idiopathic pulmonary fibrosis
by Richeldi, Luca and Richeldi, Luca
The New England journal of medicine, ISSN 0028-4793, 2014, Volume 371, Issue 8, p. 783
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Clinical trials of investigational agents for IPF: A review of a Cochrane report
by Richeldi, Luca
Respiratory research, ISSN 1465-9921, 04/2013, Volume 14, Issue 1, pp. S4 - S4
Idiopatic Pulmonary Fibrosis (IPF) | meta-analysis | investigational agents | Life Sciences & Biomedicine | Respiratory System | Science & Technology | Idiopathic Pulmonary Fibrosis - epidemiology | Prevalence | Clinical Trials as Topic - statistics & numerical data | Humans | Immunosuppressive Agents - therapeutic use | Respiratory System Agents - therapeutic use | Antibodies, Monoclonal - therapeutic use | Treatment Outcome | Adrenal Cortex Hormones - therapeutic use | Evidence-Based Medicine | Idiopathic Pulmonary Fibrosis - drug therapy | Studies | Fees & charges | Heart attacks | Mortality | Journals | Clinical trials | Peer review | Meta-analysis | Index Medicus | Review
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Current approaches to the management of idiopathic pulmonary fibrosis
by Raghu, Ganesh and Richeldi, Luca
Respiratory medicine, ISSN 0954-6111, 2017, Volume 129, pp. 24 - 30
Pulmonary/Respiratory | Interstitial lung disease | Idiopathic pulmonary fibrosis | Treatment | Cardiac & Cardiovascular Systems | Respiratory System | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Prevalence | Comorbidity | Humans | Middle Aged | Palliative Care | Enzyme Inhibitors - therapeutic use | Disease Progression | Indoles - administration & dosage | Idiopathic Pulmonary Fibrosis - epidemiology | Young Adult | Pyridones - administration & dosage | Idiopathic Pulmonary Fibrosis - diagnosis | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Adolescent | Quality of Life | Adult | Indoles - therapeutic use | Idiopathic Pulmonary Fibrosis - physiopathology | Lung Transplantation - methods | Pyridones - therapeutic use | Lung Diseases, Interstitial - physiopathology | Idiopathic Pulmonary Fibrosis - drug therapy | Patient Education as Topic | Practice Guidelines as Topic | Transplantation of organs, tissues, etc | Development and progression | Pulmonary fibrosis | Palliative treatment | Drug approval | Heart | Drugs | Respiratory function | Transplants & implants | Syngeneic grafts | Lung transplantation | Transplantation | Immunosuppressive agents | Dyspnea | Xenografts | Fitness training programs | Mortality | Lung diseases | Pharmacology | Disease control | Patients | Cough | Quality of life | Studies | Biopsy | Medical prognosis | Fibrosis | Rehabilitation | Respiration | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Idiopathic pulmonary fibrosis: Pathogenesis and management
by Sgalla, Giacomo and Iovene, Bruno and Calvello, Mariarosaria and Ori, Margherita and Varone, Francesco and Richeldi, Luca
Respiratory research, ISSN 1465-9921, 02/2018, Volume 19, Issue 1, pp. 32 - 32
Treatment | Pathogenesis | Idiopathic pulmonary fibrosis | Nintedanib | Diagnosis | Management | Interstitial lung disease | Pirfenidone | Life Sciences & Biomedicine | Respiratory System | Science & Technology | Causes of | Development and progression | Care and treatment | Pulmonary fibrosis | Research | Index Medicus | Review
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Efficacy of Nintedanib in Idiopathic Pulmonary Fibrosis across Prespecified Subgroups in INPULSIS
by Costabel, Ulrich and Costabel, Ulrich and Inoue, Yoshikazu and Inoue, Yoshikazu and Richeldi, Luca and Richeldi, Luca and Collard, Harold R and Collard, Harold R and Tschoepe, Inga and Tschoepe, Inga and Stowasser, Susanne and Stowasser, Susanne and Azuma, Arata and Azuma, Arata
American journal of respiratory and critical care medicine, ISSN 1073-449X, 01/2016, Volume 193, Issue 2, pp. 178 - 185
quality of life | forced vital capacity | disease progression | Respiratory System | Life Sciences & Biomedicine | Critical Care Medicine | General & Internal Medicine | Science & Technology | Vital Capacity - drug effects | Humans | Middle Aged | Enzyme Inhibitors - pharmacology | Female | Indoles - pharmacology | Indoles - therapeutic use | Male | Enzyme Inhibitors - therapeutic use | Disease Progression | Idiopathic Pulmonary Fibrosis - drug therapy | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Efficacy endpoints for idiopathic pulmonary fibrosis trials
by Richeldi, Luca
The lancet respiratory medicine, ISSN 2213-2600, 2015, Volume 3, Issue 5, pp. 335 - 337
Pulmonary/Respiratory | Respiratory System | Life Sciences & Biomedicine | Critical Care Medicine | General & Internal Medicine | Science & Technology | Idiopathic Pulmonary Fibrosis - mortality | Humans | Vital Capacity - physiology | Hospitalization - statistics & numerical data | Female | Male | Idiopathic Pulmonary Fibrosis - physiopathology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights